Old Web
English
Sign In
Acemap
>
authorDetail
>
Roderick A. Stegeman
Roderick A. Stegeman
Pfizer
Biochemistry
Chemistry
Stereochemistry
Indazole
Chemical synthesis
3
Papers
56
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
CDK-2 with indazole inhibitor 17 bound at its active site
2009
James R. Kiefer
Jacqueline E. Day
Nicole Caspers
Karl J. Mathis
K K Kretzmer
Robin A. Weinberg
Beverly A. Reitz
Roderick A. Stegeman
John I. Trujillo
Wei Huang
Atli Thorarensen
Li Xing
Ann D. Wrightstone
Lori Christine
Robert Compton
Xiong Li
Show All
Source
Cite
Save
Citations (0)
2-(6-Phenyl-1H-indazol-3-yl)-1H-benzo[d]imidazoles: Design and synthesis of a potent and isoform selective PKC-[zeta] inhibitor
2009
Bioorganic & Medicinal Chemistry Letters
John I. Trujillo
James R. Kiefer
Wei Huang
Atli Thorarensen
Li Xing
Nicole Caspers
Jacqueline E. Day
Karl J. Mathis
Kuniko K. Kretzmer
Beverley A. Reitz
Robin A. Weinberg
Roderick A. Stegeman
Ann D. Wrightstone
Lori Christine
Robert Compton
Xiong Li
Show All
Source
Cite
Save
Citations (45)
Structure-based design and synthesis of pyrazinones containing novel P1 'side pocket' moieties as inhibitors of TF/VIIa.
2005
Bioorganic & Medicinal Chemistry Letters
Barbara Ann Schweitzer
William L. Neumann
Hayat K. Rahman
Carrie Kusturin
Kirby Sample
Gennadiy I. Poda
Ravi G. Kurumbail
Anna M. Stevens
Roderick A. Stegeman
William C. Stallings
Michael S. South
Show All
Source
Cite
Save
Citations (11)
1